VTVT ▲ +1.2% - vTv Therapeutics Inc.
$VTVT - vTv Therapeutics Announces Completion of Enrollment in Phase 3 CATT1 Study of Cadisegliatin in Type 1 Diabetes (T1D)
05-OCT-2026 08:01 AM ET
Share this post
More filings for $VTVT
VTVT ▲ +3.7% - vTv Therapeutics Inc.Oct 10, 2026VTVT - vTv Therapeutics Inc. - SEC Filing Update (08-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 8, 2026VTVT ▲ +3.1% - vTv Therapeutics Inc.Oct 7, 2026VTVT ▲ +0.1% - vTv Therapeutics Inc.Oct 6, 2026VTVT ▼ -0.4% - vTv Therapeutics Inc.Sep 2, 2026$VTVT SEC Filing Update (29-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 29, 2026
View full $VTVT filing history →💬 Comments
Loading comments…
Leave a comment